Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferda Cevikbas

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Investigative Dermatology|April 14, 2012
IL-33: a novel danger signal system in atopic dermatitisFerda Cevikbas, Martin Steinhoff
Physiological Reviews|December 24, 2019
Physiology and Pathophysiology of ItchFerda Cevikbas, Ethan A Lerner
CNS Neuroscience & Therapeutics|October 19, 2010
Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug developmentFerda Cevikbas, Martin Steinhoff, Akihiko Ikoma
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 15, 2024
Eblasakimab, an Anti-IL‑13Rα1 Antibody, Reduces Atopy-Associated Serum Biomarkers in Moderate‑to‑Severe Atopic DermatitisFerda Cevikbas, Alison Ward, Karen A Veverka
Seminars in Cutaneous Medicine and Surgery|July 20, 2011
Anatomy and neurophysiology of pruritusAkihiko Ikoma, Ferda Cevikbas, Cordula Kempkes, et al.
Current Opinion in Allergy and Clinical Immunology|September 18, 2007
Neuroimmune interactions in allergic skin diseasesFerda Cevikbas, Antje Steinhoff, Bernhard Homey, et al.
Clinical Immunology (Orlando, Fla.)|June 14, 2023
Eblasakimab, a novel IL-13 receptor alpha 1 monoclonal antibody, blocks STAT6 phosphorylation with low dose in human volunteersFerda Cevikbas, Alison Ward, Carl Firth, et al.
Seminars in Cutaneous Medicine and Surgery|July 20, 2011
Pruritus: management algorithms and experimental therapiesMartin Steinhoff, Ferda Cevikbas, Akihiko Ikoma, et al.
Experimental Dermatology|March 3, 2019
Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approachesMatthew Moyle, Ferda Cevikbas, Jamie L Harden, et al.
Experimental Dermatology|September 21, 2010
Interferon-γ induces upregulation and activation of the interleukin-31 receptor in human dermal microvascular endothelial cellsMicha Feld, Victoria M Shpacovitch, Michaela Fastrich, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Investigative Dermatology|April 14, 2012
IL-33: a novel danger signal system in atopic dermatitisFerda Cevikbas, Martin Steinhoff
Physiological Reviews|December 24, 2019
Physiology and Pathophysiology of ItchFerda Cevikbas, Ethan A Lerner
CNS Neuroscience & Therapeutics|October 19, 2010
Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug developmentFerda Cevikbas, Martin Steinhoff, Akihiko Ikoma
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 15, 2024
Eblasakimab, an Anti-IL‑13Rα1 Antibody, Reduces Atopy-Associated Serum Biomarkers in Moderate‑to‑Severe Atopic DermatitisFerda Cevikbas, Alison Ward, Karen A Veverka
Seminars in Cutaneous Medicine and Surgery|July 20, 2011
Anatomy and neurophysiology of pruritusAkihiko Ikoma, Ferda Cevikbas, Cordula Kempkes, et al.
Current Opinion in Allergy and Clinical Immunology|September 18, 2007
Neuroimmune interactions in allergic skin diseasesFerda Cevikbas, Antje Steinhoff, Bernhard Homey, et al.
Clinical Immunology (Orlando, Fla.)|June 14, 2023
Eblasakimab, a novel IL-13 receptor alpha 1 monoclonal antibody, blocks STAT6 phosphorylation with low dose in human volunteersFerda Cevikbas, Alison Ward, Carl Firth, et al.
Seminars in Cutaneous Medicine and Surgery|July 20, 2011
Pruritus: management algorithms and experimental therapiesMartin Steinhoff, Ferda Cevikbas, Akihiko Ikoma, et al.
Experimental Dermatology|March 3, 2019
Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approachesMatthew Moyle, Ferda Cevikbas, Jamie L Harden, et al.
Experimental Dermatology|September 21, 2010
Interferon-γ induces upregulation and activation of the interleukin-31 receptor in human dermal microvascular endothelial cellsMicha Feld, Victoria M Shpacovitch, Michaela Fastrich, et al.
Pageof 4